Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.445
+0.031 (7.44%)
Mar 9, 2026, 3:27 PM EDT - Market open
Outlook Therapeutics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Revenue | 0.21 | 1.41 | - | - | - | - | Upgrade
|
| Cost of Revenue | 22.54 | 28.54 | 41.76 | 26.45 | 42.33 | 38.96 | Upgrade
|
| Gross Profit | -22.34 | -27.12 | -41.76 | -26.45 | -42.33 | -38.96 | Upgrade
|
| Selling, General & Admin | 36.6 | 39.94 | 29.94 | 26.67 | 20.74 | 12.77 | Upgrade
|
| Operating Expenses | 36.6 | 39.94 | 29.94 | 26.67 | 20.74 | 12.77 | Upgrade
|
| Operating Income | -58.94 | -67.06 | -71.7 | -53.13 | -63.07 | -51.73 | Upgrade
|
| Interest Expense | -0.28 | -0.28 | -3.16 | -2.53 | -1.49 | -0.94 | Upgrade
|
| Interest & Investment Income | 0.04 | 0.09 | 0.91 | 0.97 | - | - | Upgrade
|
| Earnings From Equity Investments | -0.15 | -0.14 | -0.1 | -0.01 | -0.05 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -33.57 | 9.49 | 1.15 | 0.05 | 0.47 | -0.45 | Upgrade
|
| EBT Excluding Unusual Items | -92.9 | -57.9 | -72.91 | -54.65 | -64.14 | -53.16 | Upgrade
|
| Other Unusual Items | -11.51 | -6.07 | -2.46 | -4.33 | -1.91 | - | Upgrade
|
| Pretax Income | -104.41 | -63.98 | -75.36 | -58.98 | -66.05 | -53.16 | Upgrade
|
| Income Tax Expense | -1.55 | -1.55 | 0 | 0 | 0 | 0 | Upgrade
|
| Earnings From Continuing Operations | -102.86 | -62.42 | -75.37 | -58.98 | -66.05 | -53.16 | Upgrade
|
| Net Income | -102.86 | -62.42 | -75.37 | -58.98 | -66.05 | -53.16 | Upgrade
|
| Net Income to Common | -102.86 | -62.42 | -75.37 | -58.98 | -66.05 | -53.16 | Upgrade
|
| Shares Outstanding (Basic) | 44 | 35 | 19 | 13 | 11 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 44 | 35 | 19 | 13 | 11 | 8 | Upgrade
|
| Shares Change (YoY) | 105.06% | 87.59% | 48.29% | 17.96% | 38.91% | 110.43% | Upgrade
|
| EPS (Basic) | -2.35 | -1.79 | -4.06 | -4.72 | -6.23 | -6.96 | Upgrade
|
| EPS (Diluted) | -2.35 | -1.79 | -4.06 | -4.72 | -6.23 | -6.96 | Upgrade
|
| Free Cash Flow | -55.8 | -51.83 | -68.79 | -42.97 | -56.67 | -54.25 | Upgrade
|
| Free Cash Flow Per Share | -1.27 | -1.49 | -3.71 | -3.44 | -5.34 | -7.11 | Upgrade
|
| Operating Margin | -28652.50% | -4744.25% | - | - | - | - | Upgrade
|
| Profit Margin | -50004.67% | -4416.22% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -27127.21% | -3666.65% | - | - | - | - | Upgrade
|
| EBITDA | -58.82 | -66.94 | -71.59 | -53.08 | -62.87 | -51.46 | Upgrade
|
| D&A For EBITDA | 0.12 | 0.12 | 0.11 | 0.04 | 0.2 | 0.26 | Upgrade
|
| EBIT | -58.94 | -67.06 | -71.7 | -53.13 | -63.07 | -51.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.